Fucoidan inhibits EGFR redistribution and potentiates sorafenib to overcome sorafenib-resistant hepatocellular carcinoma
出版年份 2022 全文链接
标题
Fucoidan inhibits EGFR redistribution and potentiates sorafenib to overcome sorafenib-resistant hepatocellular carcinoma
作者
关键词
-
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 154, Issue -, Pages 113602
出版商
Elsevier BV
发表日期
2022-08-25
DOI
10.1016/j.biopha.2022.113602
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multiwalled carbon nanotubes co-delivering sorafenib and epidermal growth factor receptor siRNA enhanced tumor-suppressing effect on liver cancer
- (2021) Zhili Wen et al. Aging-US
- Quiescin Sulfhydryl Oxidase 1 Promotes Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma by Driving EGFR Endosomal Trafficking and Inhibiting NRF2 Activation
- (2021) Jialei Sun et al. Redox Biology
- The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles
- (2021) Jun-O. Jin et al. Marine Drugs
- MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma
- (2021) Peng Xia et al. Cell Death & Disease
- Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
- (2021) Francesca Fornari et al. Journal of Hepatocellular Carcinoma
- Structural characterization of a P-selectin and EGFR dual-targeting fucoidan from Sargassum fusiforme
- (2021) Xue Liu et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Study on Absorption Mechanism and Tissue Distribution of Fucoidan
- (2020) Xu Bai et al. MOLECULES
- Fucoidan Induces Apoptosis of HT-29 Cells via the Activation of DR4 and Mitochondrial Pathway
- (2020) Xu Bai et al. Marine Drugs
- Brown Seaweed Fucoidan in Cancer: Implications in Metastasis and Drug Resistance
- (2020) María Elena Reyes et al. Marine Drugs
- miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR
- (2020) Lin Ji et al. Cell Death & Disease
- A review on fucoidan antitumor strategies: From a biological active agent to a structural component of fucoidan-based systems
- (2020) Catarina Oliveira et al. CARBOHYDRATE POLYMERS
- Fucoidan increased the sensitivity to gefitinib in lung cancer cells correlates with reduction of TGFβ-mediated Slug expression
- (2020) Wei-Lun Qiu et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Multifunctional role of fucoidan, sulfated polysaccharides in human health and disease: A journey under the sea in pursuit of potent therapeutic agents
- (2020) Biswajita Pradhan et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
- (2019) Geert van Weelden et al. Marine Drugs
- Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance Induced by Membranous/Cytoplasmic/Nuclear Translocation of Epidermal Growth Factor Receptor
- (2019) Xuezhu Rong et al. Journal of Thoracic Oncology
- “Fucoidan, a natural biopolymer in cancer combating: From edible algae to nanocarrier tailoring”
- (2019) Samar M. Etman et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Therapies from Fucoidan: New Developments
- (2019) Fitton et al. Marine Drugs
- EGFR-mediated autophagy in tumourigenesis and therapeutic resistance
- (2019) Min Wu et al. CANCER LETTERS
- miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway
- (2018) Rongchang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation
- (2018) Qiong Wu et al. Cell Death & Disease
- Mannan-binding lectin deficiency exacerbates sterile liver injury in mice through enhancing hepatic neutrophil recruitment
- (2018) Jia Zhou et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation via the ERK/COX-2/PGE2 pathway
- (2018) Junru Li et al. OncoImmunology
- Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo
- (2017) Yuan Yan et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Emerging functions of the EGFR in cancer
- (2017) Sara Sigismund et al. Molecular Oncology
- Fucoidan from Fucus vesiculosus suppresses hepatitis B virus replication by enhancing extracellular signal-regulated Kinase activation
- (2017) Huifang Li et al. Virology Journal
- Heterogeneity of liver cancer and personalized therapy
- (2016) Liang Li et al. CANCER LETTERS
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prophylactic Administration of Fucoidan Represses Cancer Metastasis by Inhibiting Vascular Endothelial Growth Factor (VEGF) and Matrix Metalloproteinases (MMPs) in Lewis Tumor-Bearing Mice
- (2015) Tse-Hung Huang et al. Marine Drugs
- Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR
- (2015) T Bertrand et al. Cell Death & Disease
- Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells
- (2014) Dali Zhao et al. CELLULAR SIGNALLING
- The EGFR Pathway Regulates BCRP Expression in NSCLC Cells: Role of Erlotinib
- (2014) Letizia Porcelli et al. CURRENT DRUG TARGETS
- Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
- (2013) Toni M. Brand et al. PLoS One
- EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
- (2012) Zakaria Ezzoukhry et al. INTERNATIONAL JOURNAL OF CANCER
- Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
- (2012) Marie-José Blivet-Van Eggelpoël et al. JOURNAL OF HEPATOLOGY
- Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells
- (2011) Wei-Chien Huang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
- (2011) K.-F. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib
- (2010) Mary E. Irwin et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nuclear EGFR contributes to acquired resistance to cetuximab
- (2009) C Li et al. ONCOGENE
- Inhibitory effects of fucoidan on activation of epidermal growth factor receptor and cell transformation in JB6 Cl41 cells
- (2008) Na Yeon Lee et al. FOOD AND CHEMICAL TOXICOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now